Not applicableUnknownNCT06001294
What this trial is testing
We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.
Who this might be right for
SepsisSeptic ShockAcute Kidney Injury
Xiangcheng Zhang 70